138 related articles for article (PubMed ID: 38229560)
1. Development, implementation and impact of an immunoglobulin stewardship programme in Saskatchewan, Canada.
Sarker K; Vanstone JR; Adigun O; Boutilier B; Comeau J; Degelman ML; Gottselig P; Berry WE; Milne A; Van Vliet P; Harding SR
Vox Sang; 2024 Apr; 119(4):335-343. PubMed ID: 38229560
[TBL] [Abstract][Full Text] [Related]
2. Economic benefits of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency.
Martin A; Lavoie L; Goetghebeur M; Schellenberg R
Transfus Med; 2013 Feb; 23(1):55-60. PubMed ID: 23167310
[TBL] [Abstract][Full Text] [Related]
3. Intravenous Immune Globulin Stewardship Program at a Tertiary Academic Medical Center.
Rocchio MA; Schurr JW; Hussey AP; Szumita PM
Ann Pharmacother; 2017 Feb; 51(2):135-139. PubMed ID: 27758967
[TBL] [Abstract][Full Text] [Related]
4. Impact of organizational interventions on reducing inappropriate intravenous immunoglobulin (IVIG) usage: A systematic review and meta-analysis.
Diep C; Shih AW; Jamula E; Heddle NM; Parvizian M; Hillis CM
Transfus Apher Sci; 2018 Apr; 57(2):215-221. PubMed ID: 29439921
[TBL] [Abstract][Full Text] [Related]
5. Changes in Intravenous Immunoglobulin Usage for Hypogammaglobulinemia After Implementation of a Stewardship Program.
Derman BA; Schlei Z; Parsad S; Mullane K; Knoebel RW
JCO Oncol Pract; 2021 Mar; 17(3):e445-e453. PubMed ID: 32822257
[TBL] [Abstract][Full Text] [Related]
6. Appropriateness of the use of intravenous immune globulin before and after the introduction of a utilization control program.
Feasby TE; Quan H; Tubman M; Pi D; Tinmouth A; So L; Ghali WA
Open Med; 2012; 6(1):e28-34. PubMed ID: 22567080
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin utilization in the Canadian Atlantic provinces: a report of the Atlantic Collaborative Intravenous Immune Globulin Utilization Working Group.
Constantine MM; Thomas W; Whitman L; Kahwash E; Dolan S; Smith S; Caudle CJ; Burton E; Anderson DR;
Transfusion; 2007 Nov; 47(11):2072-80. PubMed ID: 17958537
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin utilization in Canada: a comparative analysis of provincial guidelines and a scoping review of the literature.
Harmon M; Riazi K; Callum J; Arnold DM; Barty R; Sidhu D; Heddle NM; MacLeod L; Li N
Allergy Asthma Clin Immunol; 2023 Sep; 19(1):85. PubMed ID: 37717038
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and outcomes of paid undergraduate student nurse positions.
Gamroth L; Budgen C; Lougheed M
Nurs Leadersh (Tor Ont); 2006 Sep; 19(3):e1-14. PubMed ID: 19830923
[TBL] [Abstract][Full Text] [Related]
10. Appropriateness of intravenous immunoglobulin use in immune thrombocytopenia (ITP): A Canadian centre deep dive audit.
Liu J; Pavenski K; Sholzberg M
Transfus Apher Sci; 2019 Aug; 58(4):491-494. PubMed ID: 31105060
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis.
Soares MO; Welton NJ; Harrison DA; Peura P; Shankar- Hari M; Harvey SE; Madan JJ; Ades AE; Palmer SJ; Rowan KM
Health Technol Assess; 2012; 16(7):1-186. PubMed ID: 22361003
[TBL] [Abstract][Full Text] [Related]
12. Differentiating characteristics and evaluating intravenous and subcutaneous immunoglobulin.
Ness S
Am J Manag Care; 2019 Jun; 25(6 Suppl):S98-S104. PubMed ID: 31318515
[TBL] [Abstract][Full Text] [Related]
13. Comparative net cost impact of the utilization of romiplostim and intravenous immunoglobulin for the treatment of patients with immune thrombocytopenia in Québec, Canada.
Pettigrew M; Garces K; Deuson R; Kassis J; Laroche V
J Med Econ; 2013; 16(2):318-26. PubMed ID: 23216012
[TBL] [Abstract][Full Text] [Related]
14. A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE).
Absoud M; Brex P; Ciccarelli O; Diribe O; Giovannoni G; Hellier J; Howe R; Holland R; Kelly J; McCrone P; Murphy C; Palace J; Pickles A; Pike M; Robertson N; Jacob A; Lim M
Health Technol Assess; 2017 May; 21(31):1-50. PubMed ID: 28639937
[TBL] [Abstract][Full Text] [Related]
15. Switching Patients to Home-Based Subcutaneous Immunoglobulin: an Economic Evaluation of an Interprofessional Drug Therapy Management Program.
Perraudin C; Bourdin A; Spertini F; Berger J; Bugnon O
J Clin Immunol; 2016 Jul; 36(5):502-10. PubMed ID: 27139500
[TBL] [Abstract][Full Text] [Related]
16. Medication stewardship using computerized clinical decision support: A case study on intravenous immunoglobulins.
Tsapepas D; Der-Nigoghossian C; Patel K; Berger K; Vawdrey DK; Salmasian H
Pharmacol Res Perspect; 2019 Oct; 7(5):e00508. PubMed ID: 31485333
[TBL] [Abstract][Full Text] [Related]
17. Home-based subcutaneous immunoglobulin therapy vs hospital-based intravenous immunoglobulin therapy: A prospective economic analysis.
Fu LW; Song C; Isaranuwatchai W; Betschel S
Ann Allergy Asthma Immunol; 2018 Feb; 120(2):195-199. PubMed ID: 29413344
[TBL] [Abstract][Full Text] [Related]
18. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a Personalized Subcutaneous Immunoglobulin Treatment Program for Neurological Patients.
Suleman A; Theoret L; Bourque P; Pringle E; Cameron DW; Cowan J
Can J Neurol Sci; 2019 Jan; 46(1):38-43. PubMed ID: 30688201
[TBL] [Abstract][Full Text] [Related]
20. Trends in IVIG use at a tertiary care Canadian center and impact of provincial use mitigation strategies: 10-year retrospective study with interrupted time series analysis.
Murphy MSQ; Tinmouth A; Goldman M; Chassé M; Colas JA; Saidenberg E; Shehata N; Fergusson D; Forster AJ; Wilson K
Transfusion; 2019 Jun; 59(6):1988-1996. PubMed ID: 30916409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
